ScripsAmerica Expands Specialty Pharmacy Operations to Include 12 Additional States Through New Sourcing Agreement
Marketwire - Tue Sep 16, 7:02AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has entered into a prescription sourcing agreement with Ohio-based Jungle Jim's International Market, which has pharmacy licenses in several states.
ScripsAmerica Expands Specialty Pharmacy Operations Through Prescription Sourcing Agreement With United Apothecary, Inc.
Marketwire - Mon Sep 08, 7:03AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has signed a prescription sourcing agreement with United Apothecary, Inc., a pharmacy based in Oak Ridge, TN.
ScripsAmerica's Specialty Pharmacy Continues Revenue Growth With $4.9 Million in Approved Orders for August
Marketwire - Wed Sep 03, 7:01AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $4,867,637 in approved orders during the month of August 2014, marking its fifth consecutive month of sales growth.
ScripsAmerica Comments on 10-Q for the Second Quarter of 2014
Marketwire - Mon Aug 18, 7:01AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), today commented on the Company's recent 10-Q filing for the second quarter ended June 30, 2014.
Ironridge Global IV, Ltd. Successfully Obtains Final Enforcement Order Against ScripsAmerica, Inc.
ACCESSWIRE - Wed Aug 13, 3:31PM CDT
Los Angeles, CA / ACCESSWIRE / August 13, 2014 / Ironridge Global IV, Ltd. has obtained a final order against ScripsAmerica, Inc. (OTCBB: SCRC), fully upholding the original stipulated settlement agreement of the parties.
ScripsAmerica's Specialty Pharmacy Receives Approved Orders of $4.1 Million in July Marking Its Fourth Consecutive Month of Sales Growth
Marketwire - Mon Aug 04, 7:00AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $4,090,000 in approved orders during the month of July 2014.
ScripsAmerica's Managed Specialty Pharmacy on Pace for Record Month
Marketwire - Mon Jul 21, 7:01AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $1.5 million in approved prescription orders during the first half of July.
Wholesale Rx, ScripsAmerica's Equity Venture, Reports Significant YoY Revenue Growth During Q2 2014
Marketwire - Mon Jul 14, 7:30AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $696,808 in orders during the quarter ended June 30, 2014 compared to $26,000 during the same quarter in 2013, prior to ScripsAmerica's involvement with the company.
ScripsAmerica's Equity Venture, Wholesale Rx, Reports 93% Revenue Growth During the First Quarter of 2014
Marketwire - Wed Jul 09, 7:30AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," reported quarterly revenue growth of 93% from Q4 2013 to Q1 2014.
ScripsAmerica's Managed Specialty Pharmacy Receives Approved Orders of $2.7 Million in June
Marketwire - Mon Jul 07, 7:30AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $2,706,709 in prescription approved orders during the month of June.
ScripsAmerica Completes Prepayment of Outstanding Convertible Debt
Marketwire - Mon Jun 23, 8:15AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has completed the prepayment of its outstanding convertible debt.
ScripsAmerica Issues Second Payment on Largest Convertible Note
GlobeNewswire - Wed Apr 02, 8:43AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has issued the second payment due on its convertible note with the largest principal and closest conversion date.
ScripsAmerica Reports March Revenue of Over $494,000 for Its Managed Specialty Pharmacy
GlobeNewswire - Tue Apr 01, 8:25AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the specialty pharmacy it recently entered into a management agreement with recorded $494,643 in prescription sales for the month of March.
ScripsAmerica Prepays $50,000 Convertible Promissory Note
GlobeNewswire - Mon Mar 31, 7:30AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced the prepayment of an outstanding convertible note in the principal amount of $50,000.
ScripsAmerica's Pharmaceutical Equity Venture, Wholesale Rx, Continues Revenue Growth in February
GlobeNewswire - Mon Mar 24, 7:33AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $313,904 in orders during the month of February.
ScripsAmerica Prepays Another Convertible Promissory Note
GlobeNewswire - Mon Mar 17, 7:30AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid the entire balance of an outstanding convertible promissory note with a principal amount of $50,000.
ScripsAmerica Announces Prepayment of Convertible Promissory Note
GlobeNewswire - Wed Mar 12, 7:46AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid the balance of an outstanding convertible promissory note with a principal amount of $40,000.
ScripsAmerica Secures $200,000 RapiMed Purchase Order for Hong Kong Market
GlobeNewswire - Mon Mar 10, 9:02AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has secured a $200,000 purchase order for RapiMed(R) from Global Pharma Hub for the Hong Kong market.
ScripsAmerica Enters Licensing Agreement to Market and Distribute RapiMed in Canada
GlobeNewswire - Wed Mar 05, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a sublicensing agreement for the marketing and distribution of RapiMed(R) in Canada. ScripsAmerica will now have access to the growing Canadian OTC drug market, which was valued at over $3.1 Billion in 2012.
ScripsAmerica Signs Business Management Agreement With a New Jersey Compounding Pharmacy
GlobeNewswire - Thu Feb 20, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a business management agreement with a New Jersey compounding pharmacy.